New Delhi: The World Health Organisation (WHO) has suspended the procurement of Covaxin, produced by Bharat Biotech, through UN agencies, NDTV reported. It said the step has been taken to allow the manufacturer to upgrade facilities and address deficiencies found in an inspection.
The WHO clarified that the vaccine is effective and no safety concerns exist.
Hyderabad-based Bharat Biotech on Sunday said there is “no impact on efficacy and safety of Covaxin”. “For the millions who have received Covaxin, the vaccine certificates issued still stand valid as there is no impact on efficacy and safety of the vaccine,” Bharat Biotech said in the statement, according to ANI.
WHO said the suspension followed an emergency use listing (EUL) inspection conducted from March 14 to 22.
Bhubaneswar: The Odisha Human Rights Commission (OHRC) has sent notices to Secretaries of Food &…
New Delhi: Even as his recently-released horror comedy ‘Bhool Bhulaiyaa 3’ continues to mint money…
New Delhi/Bhubaneswar: After over 20 days of investigation and analysing more than 700 CCTV cameras,…
New Delhi: The Delhi High Court has closed proceedings on a petition challenging the Rajiv…
Mumbai: ‘12th Fail’ actor Vikrant Massey recently got trolled after pictures of him touching his…
Mumbai: Mumbai Police swung into action immediately after Bollywood superstar Shah Rukh Khan received a…
Dubai: The effects of global climate change are being seen in various manifestations across the globe.…
Mumbai: When criminals are idolised and used for commercial purposes, police are bound to take action.…